ETF Tracker Newsletter For May 22, 2020

Ulli ETF Tracker Contact

ETF Tracker StatSheet           You can view the latest version here. RUNNING OUT OF STEAM [Chart courtesy of MarketWatch.com] Moving the markets Despite a heroic attempt to pump the market into another green close, the computer algos pushed the major indexes back toward their respective unchanged lines, but not much was gained, as the bullish theme ran out of steam …

Weekly StatSheet For The ETF Tracker Newsletter – Updated Through 05/21/2020

Ulli ETF StatSheet Contact

ETF Data updated through Thursday, May 21, 2020 Methodology/Use of this StatSheet: 1. From the universe of over 1,800 ETFs, I have selected only those with a trading volume of over $5 million per day (HV ETFs), so that liquidity and a small bid/ask spread are assured. 2. Trend Tracking Indexes (TTIs) Buy or Sell decisions for Domestic and International …

Levitating Higher

Ulli Market Commentary Contact

[Chart courtesy of MarketWatch.com] Moving the markets Today, upbeat quarterly earnings results from Target and Lowe’s set a positive tone and sent the major indexes to 10-week highs. However, as soon as news of a bill to delist Chinese companies from the US exchanges cleared the senate, equities came off their best levels of the day. The focus remained predominantly …

Vaccine Stock Moderna Pops And Then Drops

Ulli Market Commentary Contact

[Chart courtesy of MarketWatch.com] Moving the markets While the jury is still out whether we’re experiencing a bear market bounce or have moved into a new bullish cycle, I was surprised to read that two-thirds of fund managers are saying we’re still in a bear market rally. I agree with that but will change my mind once our Trend Tracking …

A One-Two Punch Rockets Markets Higher

Ulli Market Commentary Contact

[Chart courtesy of MarketWatch.com] Moving the markets The futures started things out by rallying sharply based on Europe data showing new corona virus cases growing at the slowest rate in months. That was followed by the US markets jumping right after the opening bell, because of drug maker Moderna announcing positive early results from its first human trial of its …